EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 67 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,417 | -24.0% | 10,500 | -0.0% | 0.00% | – |
| Q4 2022 | $12,392 | -84.7% | 10,502 | -2.2% | 0.00% | – |
| Q3 2022 | $81,000 | +22.7% | 10,737 | +1.8% | 0.00% | – |
| Q2 2022 | $66,000 | -96.1% | 10,545 | -92.4% | 0.00% | -100.0% |
| Q4 2020 | $1,702,000 | +62.2% | 138,481 | +7.4% | 0.00% | 0.0% |
| Q3 2020 | $1,049,000 | -16.5% | 128,952 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $1,256,000 | +63.5% | 130,803 | +15.8% | 0.00% | 0.0% |
| Q1 2020 | $768,000 | -45.5% | 112,999 | +19.5% | 0.00% | 0.0% |
| Q4 2019 | $1,409,000 | +1.4% | 94,561 | -30.3% | 0.00% | 0.0% |
| Q3 2019 | $1,390,000 | – | 135,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
| P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
| Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
| 683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
| KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
| Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
| TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
| Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
| CAXTON CORP | 94,083 | $833,000 | 0.54% |